Rockwell Medical, Inc. Announces Submission of New Drug Application for I.V. Triferic®
29 mai 2019 06h50 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 29, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients...
Rockwell Medical, Inc. Reports First Quarter 2019 Financial Results
09 mai 2019 16h01 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 09, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients...
Rockwell Medical, Inc. Commences Commercial Sales of Dialysate Triferic® in the U.S.
06 mai 2019 06h50 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a global biopharmaceutical company dedicated to improving outcomes for...
Rockwell Medical, Inc. to Discuss First Quarter 2019 Financial Results on May 9, 2019
02 mai 2019 16h30 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 02, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 first quarter...
CMS Issues Preliminary Recommendation to Establish a New J-Code for Triferic® Powder Packet
01 mai 2019 16h30 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 01, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company"), a global biopharmaceutical company dedicated to improving outcomes for patients with end-stage...
Rockwell Medical, Inc. to Present at H.C Wainwright Global Life Sciences Conference
03 avr. 2019 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., April 03, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present...
Rockwell Medical, Inc. to Present at Sidoti & Company LLC Spring 2019 Investor Conference
20 mars 2019 16h30 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., March 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present...
Rockwell Medical Announces I.V. Triferic® and Peritoneal Dialysis Study Abstracts Selected as Best-in-Category at the Annual Dialysis Conference
18 mars 2019 06h50 HE
|
Rockwell Medical, Inc.
I.V. Triferic Data to Support Upcoming New Drug Application Intraperitoneal Triferic Effectively Delivers Iron to Patients with Kidney Failure in Outpatient Setting WIXOM, Mich., March 18, 2019 ...
Rockwell Medical, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
14 mars 2019 06h50 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., March 14, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company"), a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019
06 mars 2019 16h30 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., March 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2018 fourth quarter and...